DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Sibrafiban
Sibrafiban
(12) United States Patent (10) Patent No.: US 8,697,347 B2
Antithrombotic Treatment After Stroke Due to Intracerebral Haemorrhage (Review)
(12) United States Patent (10) Patent No.: US 6,518,244 B2 Cardin Et Al
Antithrombotic Agents in the Management of Sepsis
Undergoing Elective Angioplasty in Patients with Stable Coronary Artery
Antiplatelet Therapy in Cardiovascular Disease M W H Behan, R F Storey
A Aaas. See Abdominal Aortic Aneurysms Aads. See Adjuvant
Stembook 2018.Pdf
(12) United States Patent (10) Patent No.: US 9,314.499 B2 Wang Et Al
Reproductive Health Guideline Appendix 3 – Search Strategies
United States Patent (19) 11 Patent Number: 6,136,794 Cook Et Al
Platelet Glycoprotein Iib/Iiia Antagonists Pharmacology and Clinical Developments Peter C
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Additional Articles Abstracted in Acp Journal Club
(12) Patent Application Publication (10) Pub. No.: US 2014/0227350 A1 Wang Et Al
(12) Patent Application Publication (10) Pub. No.: US 2010/0221697 A1 SEHGAL (43) Pub
Pharmaabkommen A1 E
Top View
Customs Tariff - Schedule Xxi - 1
WO 2010/024870 Al
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Customs Tariff - Schedule Xxi - 1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
Wo 2009/005646 A2
<I>In Vitro</I> Biotransformation of the New Oral
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
Wo 2010/005480 A2
Harmonized Tariff Schedule of the United States (2006) (Rev
Platelet Glycoprotein Iib/Iiia Receptor Blockade in Coronary Artery Disease Jassim Al Suwaidi and Amar M Salam
MICROMEDEX® Healthcare Series Document
Cessation of Platelet-Mediated Cyclic Canine Coronary Occlusion After
Antithrombotic Treatment After Stroke Due to Intracerebral Haemorrhage
Pharmacokinetics of the Amidine Prodrug of a Novel Oral Anticoagulant Factor Viia Inhibitor (AS1924269-00) in Rats
Assessment of the Risk of Hepatotoxicity with Kava Products WHO Library Cataloguing-In-Publication Data